A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson’s disease, potentially replacing the need for daily pills.Scientists from the University of South Australia (UniSA) developed a long-acting injectable formulation that provides two key Parkinson’s medications for an entire week.There is currently no cure for Parkinson’s, which is the second-most common neurological disorder, affecting more than one million Americans, according to the Parkinson's Foundation.STANFORD SCIENTISTS 'TOTALLY SURPRISED' BY POTENTIAL PARKINSON'S TREATMENT DISCOVERYTo manage symptoms like tremors, rigidity and slow movement, patients typically take daily oral medications, such as levodopa and carbidopa, according









